Clinical Trials
3 trialsNCT01990209 2022-06-30
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01549951 2016-06-01
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
Millennium Pharmaceuticals, Inc.
Phase 2 Completed
NCT01046916 2016-04-04
Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen
Millennium Pharmaceuticals, Inc.
Phase 2 Completed